Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:37 UTC |
---|
HMDB ID | HMDB0014441 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Ropivacaine |
---|
Description | Ropivacaine is only found in individuals that have used or taken this drug. It is a local anaesthetic drug belonging to the amino amide group. The name ropivacaine refers to both the racemate and the marketed S-enantiomer. Ropivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Naropin. [Wikipedia ]Local anesthetics such as Ropivacaine block the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. Specifically, they block the sodium-channel and decrease chances of depolarization and consequent action potentials. In general, the progression of anesthesia is related to the diameter, myelination and conduction velocity of affected nerve fibers. |
---|
Structure | CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C InChI=1S/C17H26N2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20)/t15-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(-)-1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilide | ChEBI | (-)-1-Propyl-2',6'-pipecoloxylidide | ChEBI | (S)-(-)-1-Propyl-2',6'-pipecoloxylidide | ChEBI | L-N-N-Propylpipecolic acid-2,6-xylidide | ChEBI | Ropivacaina | ChEBI | Ropivacainum | ChEBI | Naropin | Kegg | L-N-N-Propylpipecolate-2,6-xylidide | Generator | S-Ropivacaine | HMDB | LEA-103 | HMDB | Naropeine | HMDB | Ropivacaine hydrochloride | HMDB | Ropivacaine monohydrochloride | HMDB | Ropivacaine monohydrochloride, (S)-isomer | HMDB | 1-Propyl-2',6'-pipecoloxylidide | HMDB | LEA 103 | HMDB | 1 Propyl 2',6' pipecoloxylidide | HMDB |
|
---|
Chemical Formula | C17H26N2O |
---|
Average Molecular Weight | 274.4011 |
---|
Monoisotopic Molecular Weight | 274.204513464 |
---|
IUPAC Name | (2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide |
---|
Traditional Name | ropivacaine |
---|
CAS Registry Number | 84057-95-4 |
---|
SMILES | CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C |
---|
InChI Identifier | InChI=1S/C17H26N2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20)/t15-/m0/s1 |
---|
InChI Key | ZKMNUMMKYBVTFN-HNNXBMFYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Alpha amino acid amides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-amino acid amide
- 2-piperidinecarboxamide
- Piperidinecarboxamide
- Anilide
- M-xylene
- Xylene
- N-arylamide
- Monocyclic benzene moiety
- Benzenoid
- Piperidine
- Carboxamide group
- Tertiary aliphatic amine
- Tertiary amine
- Secondary carboxylic acid amide
- Azacycle
- Organoheterocyclic compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Carbonyl group
- Organic oxygen compound
- Amine
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.25 g/L | Not Available | LogP | 3 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Ropivacaine,1TMS,isomer #1 | CCCN1CCCC[C@H]1C(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C | 2084.9 | Semi standard non polar | 33892256 | Ropivacaine,1TMS,isomer #1 | CCCN1CCCC[C@H]1C(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C | 2147.0 | Standard non polar | 33892256 | Ropivacaine,1TMS,isomer #1 | CCCN1CCCC[C@H]1C(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C | 2779.2 | Standard polar | 33892256 | Ropivacaine,1TBDMS,isomer #1 | CCCN1CCCC[C@H]1C(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C(C)(C)C | 2307.7 | Semi standard non polar | 33892256 | Ropivacaine,1TBDMS,isomer #1 | CCCN1CCCC[C@H]1C(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C(C)(C)C | 2372.7 | Standard non polar | 33892256 | Ropivacaine,1TBDMS,isomer #1 | CCCN1CCCC[C@H]1C(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C(C)(C)C | 2878.0 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Ropivacaine GC-MS (Non-derivatized) - 70eV, Positive | splash10-006t-8920000000-73e85079216552ba91a9 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ropivacaine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ropivacaine 10V, Positive-QTOF | splash10-00b9-0970000000-5c1a64ae27aff997890c | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ropivacaine 20V, Positive-QTOF | splash10-00fr-2900000000-672e3b8722fe16738c24 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ropivacaine 40V, Positive-QTOF | splash10-0006-9200000000-082eb7de53612f8e41d3 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ropivacaine 10V, Negative-QTOF | splash10-00di-0290000000-0bab56be469e7bd6a507 | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ropivacaine 20V, Negative-QTOF | splash10-00di-0960000000-9f382933eb477808418c | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ropivacaine 40V, Negative-QTOF | splash10-00xr-6900000000-85680fbf3993e3ad0b26 | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ropivacaine 10V, Negative-QTOF | splash10-00di-0090000000-f65ed1883e2d82087854 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ropivacaine 20V, Negative-QTOF | splash10-00di-0590000000-0e618e825ce0a7c6f894 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ropivacaine 40V, Negative-QTOF | splash10-00yi-2910000000-3a2ddfb03e07c24ab3b3 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ropivacaine 10V, Positive-QTOF | splash10-004i-0190000000-5ca58a328a550062ca9f | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ropivacaine 20V, Positive-QTOF | splash10-004i-2910000000-0b84aebef101786ad64a | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ropivacaine 40V, Positive-QTOF | splash10-004j-5900000000-12d6c869d1aa71a3e37b | 2021-09-23 | Wishart Lab | View Spectrum |
|
---|
General References | - Weinberg G, Ripper R, Feinstein DL, Hoffman W: Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med. 2003 May-Jun;28(3):198-202. [PubMed:12772136 ]
- Picard J, Meek T: Lipid emulsion to treat overdose of local anaesthetic: the gift of the glob. Anaesthesia. 2006 Feb;61(2):107-9. [PubMed:16430560 ]
- Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB: Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology. 2006 Jul;105(1):217-8. [PubMed:16810015 ]
|
---|